Clinical trial Recruiting at 1 site Interventional Ages 14 to 30

HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults

Official title: Differential Effects of HIIT vs. TRE on Type 2 Diabetes Risk in Youth and Younger Adults

Run by Syracuse University · NCT07215533 · Data updated 2026-11-12

This project will test whether 4 weeks of high-intensity interval training or time-restricted eating improves heart and metabolic health in adolescents and young adults with overweight or obesity.

More Metabolic Diseases trials

Quick facts

Study typeInterventional
Ages14 Years to 30 Years
SexAll
Enrollment40 (estimated)
SponsorSyracuse University
Academic / other
Drugs / interventionsPrednisone
Locations1 site (Syracuse, New York)
StatusRecruiting
StartedMarch 15, 2024
Main results expectedSeptember 30, 2025
Study endsDecember 30, 2025
Registry record updatedOctober 10, 2025
Trial IDNCT07215533 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 14–17 year-olds with sex- and race-specific BMI percentile ≥85th or 18–30 year-olds with BMI ≥25 kg/m2 who are otherwise healthy and not taking excluded medications.

Probably not a fit

Patients with existing chronic diseases (including diagnosed diabetes), those on excluded cardiovascular, endocrine, or psychotropic medications, or those with implanted devices like a pacemaker are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial enrolls adolescents (14–17 years with BMI percentile ≥85th) and young adults (18–30 years with BMI ≥25 kg/m2) with overweight or obesity and randomly assigns them to a 4-week high-intensity interval training (HIIT) program or a time-restricted eating (TRE) schedule. The primary outcomes are changes in cardiometabolic biomarkers measured before and after the intervention, such as insulin sensitivity, blood lipids, and other metabolic indicators. Participants with major chronic medical conditions or on excluded medications are not eligible, and interventions are delivered at Syracuse University with close monitoring. The design focuses on short-term physiological responses to lifestyle changes that are feasible for adolescents and young adults.

Why it matters

Potential benefit: If successful, the interventions could lead to improved insulin sensitivity and other cardiometabolic markers that lower short-term risk factors for type 2 diabetes in youth with overweight or obesity.

How similar studies have gone: Prior research has shown that HIIT and TRE can each improve metabolic markers in adults, but short-term randomized comparisons in adolescents and young adults are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescents (age 14-17 years old with sex- and race-specific BMI percentile ≥85th) and young adults with overweight and obesity (age 18 to 30 years old with BMI ≥25 kg/m2)

Exclusion Criteria:

* Chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV).
* Have taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti- hypertensive, endocrinologic (e.g., thyroid, insulin, etc.), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications (anabolic steroids).
* Have a pacemaker.

Where it's running

  • Syracuse University
    Syracuse, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.